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Abstract
Objective—Report of a 16q24.1 deletion in a premature newborn, demonstrating the usefulness
of array-CGH in persistent pulmonary hypertension of the newborn (PPHN) and multiple
congenital malformations.
Design—Descriptive case report
Setting—Genetic department and neonatal intensive care unit of a tertiary care children’s
hospital
Patient—We report the case of a preterm male infant, born at 26 weeks of gestation. A cardiac
malformation and bilateral hydronephrosis were diagnosed at 19 weeks of gestation. Karyotype
analysis was normal and a 22q11.2 microdeletion was excluded by FISH analysis. A Caesarean
section was performed due to fetal distress. The patient developed persistent pulmonary
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hypertension unresponsive to mechanical ventilation and nitric oxide treatment and expired at 16
hours of life. An autopsy revealed partial atrio-ventricular canal malformation and showed
bilateral dilatation of the renal pelvocaliceal system with bilateral ureteral stenosis, and annular
pancreas. Array-CGH analysis (Agilent oligoNT 44K) showed an interstitial microdeletion
encompassing the FOX gene cluster in 16q24.1. Review of the pulmonary microscopic
examination showed the characteristic features of alveolar capillary dysplasia with misalignment
of pulmonary veins (ACD/MPV). Some features were less prominent due to the gestational age.
Conclusions—Our review of the literature shows that ACD/MPV is rare, but probably
underreported. Prematurity is not a usual presentation and histological features are difficult to
interpret. In our case, array-CGH revealed a 16q24.1 deletion leading to the final diagnosis of
ACD/MPV. It emphasises the usefulness of array-CGH analysis as a diagnostic tool with
implications for both prognosis and management decisions in newborns with refractory PPHN and
multiple congenital malformations.
Keywords
persistent pulmonary hypertension of the newborn; alveolar capillary dysplasia with misalignment
of pulmonary veins; ACD/MPV; 16q24.1; neonate; array-CGH
INTRODUCTION
Persistent pulmonary hypertension of the newborn (PPHN) is characterized by failure to
achieve or sustain the normal decrease of pulmonary vascular resistance at birth. It is
associated with right to left shunting of blood across the patent ductus arteriosus and/or the
foramen ovale, leading to hypoxemia [1]. Its incidence is about 1: 1000 live births [2].
PPHN can be primary or secondary to a variety of disorders including fetal or perinatal
hypoxia, sepsis, pneumonia, meconium aspiration, congenital diaphragmatic hernia,
pulmonary hypoplasia, premature closure of the ductus arteriosus, veno-occlusive disease,
capillary hemangiomatosis and congenital heart disease, including pulmonary vein stenosis
[1]. Alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV) is a
rare interstitial lung disease affecting primarily the alveolar components [3]. It is recognized
as a cause of PPHN [4]. About 200 cases of this lethal developmental disorder of the lung
have been reported in the literature [5-7]. The histological features supporting the diagnosis
of ACD/MPV were described first in 1981 by Janney [8]. They are characterized by a
marked paucity of capillaries adjacent to the alveolar epithelium, anomalous small veins
within the bronchioarterial bundles, and medial thickening of small pulmonary arteries.
Lymphangiectasis is commonly observed, but is not universal feature of ACD/MPV [9].
ACD/MPV exact incidence is unknown and the diagnosis may be missed even on
histological examination as some expertise on the part of the pathologist is required. In the
majority of cases, affected infants are full-term newborns. Apgar scores are usually normal
and respiratory deterioration occurs in the first hours to days of life, with the development of
respiratory distress and severe pulmonary hypertension. The patients fail to respond to
various supportive strategies of management including conventional or high-frequency
ventilation, inhaled nitric oxide and extracorporeal membrane oxygenation (ECMO) [4, 7,
10-12]. The majority expire within 4 to 6 weeks of birth, although late presentation has been
reported [11, 13-15]. Up to 80% of reported patients have additional malformations,
affecting predominantly the gastro-intestinal, cardiac and genito-urinary systems [7, 10, 16,
17]. Although familial cases occur, most cases are sporadic and no genetic etiology
supported the diagnosis until recently. FOX gene cluster deletions in 16q24.1 and FOXF1
point mutations have been identified in several cases of ACD/MPV associated with other
congenital anomalies [18, 19]. We report the clinical course and cytogenetic data of a new
Zufferey et al. Page 2
Pediatr Crit Care Med. Author manuscript; available in PMC 2013 May 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
case of 16q24.1 deletion and discuss recent insights into the etiology of ACD/MVP that
illustrate the diagnostic and prognostic value of array-CGH in clinical practice.
SUBJECT AND METHODS
A preterm male infant was born at 26 weeks of gestation by emergency caesarean section
due to fetal distress. He was the first child of a nonconsanguineous Caucasian couple.
During pregnancy, the 2nd trimester fetal ultrasound revealed a cardiac malformation (partial
atrio-ventricular canal defect) and bilateral pelvocaliceal dilatation. Cultured amniotic cells
showed a normal 46,XY karyotype and FISH analysis excluded a 22q11.2 microdeletion.
Apgar score was 5 at 1′ and 8 at 5′. The patient was intubated due to inadequate respiratory
efforts. He remained hypoxemic (PaO2 30 mmHg) despite surfactant treatment and
mechanical ventilation with 100% oxygen. Echocardiography confirmed the partial
atrioventricular canal and showed suprasystemic pulmonary hypertension with a right to left
shunt across the ductus arteriosus. Treatment with inhaled nitric oxide, dopamine and
volume failed to improve oxygenation and the patient expired at 16 hours of life from
hypoxemic respiratory failure. After informed consent an autopsy and complementary
genetic analyses were performed.Growth parameters include weight of 592.4 g (appropriate
for 24 weeks of gestation), crown-heel length 32.5 cm (appropriate for 26 weeks of
gestation), head circumference 21.5 cm, without evidence for symmetric intrauterine growth
retardation.
On internal examination the organs were normally located. The heart showed partial AV
canal malformation with dysplastic tricuspid valve and two mitral valve leaflets. The
pulmonary artery appeared somewhat small. Both kidneys showed dilatation of the
pelvocaliceal system with proximal ureteral stenosis on the left and distal stenosis on the
right. There was no tracheoesophageal fistula, but there was annular pancreas with duodenal
dilatation proximal to the pancreas. The remainder of the small intestine and colon were well
positioned and no stenosis, atresia, or malrotation was identified.
Histology of the placenta showed evidence of intrauterine infection with funisitis,
chorioamnionitis, subchorionic fibrin deposits, and vasculitis and thrombosis at the insertion
of the umbilical vessels. The umbilical cord had the usual three vessels. There were no other
abnormal findings.
The lungs showed the characteristic features of ACD/MPV (Figure 1). Microscopic
examination was similar in all five lobes. Some features were less prominent than usual due
to the gestational age. Capillaries were reduced in normal locations, beyond that typically
seen at this gestational age. Small pulmonary arteries were not as prominent as often seen in
ACD/MPV, but showed mildly increased amounts of smooth muscle within their walls and
typically adjacent markedly dilated thin-walled venous channels. There were also signs of
congenital pneumonia.
Genomic DNA from the patient was isolated from uncultured skin fibroblasts collected after
death. Array CGH analysis was performed using Agilent oligoNT 44K [20]. Array CGH
demonstrated a deletion in 16q24.1 encompassing the FOX gene cluster (Figure 2). The size
of the deletion was estimated at 1.57 Mb. This region contained five annotated genes (IRF8,
FOXF1, MTHFSD, FOXC2, and FOXL1). Metaphase FISH could not be achieved because
of fibroblast culture failure, probably due to a delay between death and specimen collection.
Interphase FISH was performed on paraffin slides of pulmonary, hepatic and duodenal
sections, using a 16q24-specific BAC clone probe, RP11-542M13. The results were
consistent with a heterozygote deletion in all three tissues (Figure 3). Parental samplings are
still pending.
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A high-resolution genome wide 2.1 M Nimblegen array (Roche NimbleGen, Madison, WI,
USA) and long-range PCR was used to determine the breakpoints [18]. An 8kb PCR product
spanning the deletion junction was generated and DNA sequence analysis enabled
breakpoint sequencing. The deletion was 1,611,503 bp in size and extended between
ch16:83,666,210-85,277,713 (build NCBI 36). At the junction, there was a 25 bp AT-rich
insertion TTTATTTTATTTTATTTTATTTTTA. The distal breakpoint mapped in AluYa5
and the proximal within this unique AT-rich sequence, suggesting that the event arose as a
microhomology-mediated replication error repair, concordant with the previous published
cases [18].
DISCUSSION
We report a new case of a 16q24.1 deletion encompassing the FOX gene cluster. Array-
CGH allowed the diagnosis of this new syndrome associated with ACD/MPV. Six cases of
ACD/MPV associated with FOXF1 gene deletion or mutation were included in the initial
study and only one supplementary case report has been reported until now [18, 19]. All
cases were full term newborns. As in the present case, malformations associated with ACD/
MPV are multiple, variable in severity, and may resemble VACTERL spectrum anomalies
[21]. Intestinal atresia and malrotation are the two more commonly reported gastro-intestinal
malformations. Others included annular pancreas, imperforate anus and congenital short
bowel. Cardiac anomalies include hypoplastic left heart syndrome, hypoplasia or coarctation
of the aortic arch, tetralogy of Fallot, patent ductus arteriosus and atrial septal defect.
Hydronephrosis and pelviectasis are the more frequent urinary tract anomalies.
Prior to identification of the associated genetic abnormalities in FOXF1, ACD/MVP was
considered to be a rare syndromic entity, but was likely underdiagnosed, depending on i)
clinical suspicion, ii) biopsy and/or autopsy rate and iii) possible misinterpretation of
pathologic findings [11, 16]. Neonatologist awareness is essential in considering ACD/MPV
among causes of PPHN. In the recent literature, open lung biopsy has been proposed as a
means for early diagnosis of fatal lung dysplasia [17, 22-25]. In practice, it is performed
only in tertiary centres on a limited number of cases and diagnosis is more often made at
post mortem examination. Despite the usefulness of autopsy in establishing cause of death
and associated comorbidities and complications of therapy, autopsy rates have been
declining worldwide over the last decades. Table 1 shows the results of 7 retrospective
studies of paediatric ECMO and/or diagnostic lung biopsy. Even with these data, it remains
impossible to assess the incidence of ACD/MVP. Nevertheless, available data clearly
indicate that ACD/MPV diagnosis represents an important proportion of lethal cases among
neonates with PPHN [10, 22-23, 25-29]. Tibbals and Chow [26] retrospectively diagnosed
ACD/MPV in 6 newborns while reviewing lung tissue from 13 cases of “idiopathic” PPHN.
Congenital heart disease was an exclusion criterion in this study, inappropriately as it is now
understood that congenital cardiac abnormalities are often present in ACD/MPV. The
histological criteria of ACD/MPV are well defined but pathologists may have limited
experience with this rare condition and special expertise may be necessary for definitive
diagnosis as circumstances such as prematurity in this case may subtly alter diagnostic
features.
In our opinion, genetic testing should now be offered as a first line diagnostic tool for
suspected idiopathic PPHN. As congenital cardiac and/or intestinal malformations are
present in the vast majority of cases, their association with treatment refractory primary
PPHN should prompt array-CGH analysis. Screening for FOXF1 mutations should also be
considered. As the outcome of ACD/MPV is uniformly lethal, the identification of 16q24.1
deletion could avoid further invasive diagnostic or therapeutic procedures. Definitive
diagnosis is paramount in the case of lethal neonatal disorders as it permits accurate genetic
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counselling. ACD/MPV is genetically heterogeneous. Familial cases of ACD/MPV account
for about 10% of reported cases. Multiple affected siblings born to both consanguinous and
non-consanguinous parents initially oriented towards an autosomal recessive model [5, 7,
30, 31]. FOXF1 haploinsufficiency might be responsible for about 30-40 % of sporadic
ACD/MPV cases (Stankiewicz, Langston, unpublished data). In Stankiewicz’s series [18],
16q24.1 microdeletions arose de novo except one sparing FOXF1 gene, which was
maternally inherited. Based on these data, the risk for recurrence should be low although the
possibility of germline mosaicism cannot be completely excluded. Prenatal diagnosis might
be recommended for subsequent pregnancies using array-CGH or FISH analyses.
This case supports the usefulness of systematic genetic investigation in multiple congenital
abnormalities [32]. The application of array-CGH in the setting of congenital malformations
has brought significant insights, currently mostly in defined cohorts [33]. Its clinical
diagnosis validity has been proven and new microdeletion/duplication syndromes are
continually being delineated. Increased awareness of its value in neonatology and paediatric
departments could provide important new information in this area.
CONCLUSIONS
In conclusion, we identified a 16q24.1 deletion in a premature newborn with ACD/MPV,
cardiac, urinary and intestinal malformations. ACD/MPV is a probably underdiagnosed
developmental lung disorder. Its diagnosis remains challenging and needs pathological
expert advice. The diagnosis should be considered in neonates presenting with refractory
primary PPHN and multiple congenital malformations. The use of array-CGH as a
diagnostic tool in the management of such patients will permit accurate clinical decision
making and genetic counselling. By extension, this case highlights the importance and the
new perspectives brought by the use of this technique in patients with congenital
malformations.
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Figure 1. Lung histopathology of ACD/MPV
HE staining, × 100. The lobular architecture is altered with enlarged simplified and poorly
subdivided alveoli. Small pulmonary arteries adjacent to bronchioles show mildly increased
amounts of smooth muscle within their walls; there are abnormally positioned markedly
dilated thin-walled veins adjacent to these small pulmonary arteries. Capillaries cannot be
clearly delineated at this magnification, but they are deficient in numbers in the thickened
alveolar walls, where there are larger centrally located dilated thin-walled vascular channels.
Clusters of neutrophils are evident in some airspaces (perinatal pneumonia).
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Figure 2. Array-CGH (Agilent 44K) showing the 16q24.1 deletion
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Figure 3. Interphase FISH on paraffin sections of lung biopsy
Using a 16q24-specific BAC clone, RP11-542M13 (red), and a control chromosome 16
heterochromatic probe pHUR195 (green), more than 90% of analysed nuclei showed a
single red signal in 16q24.1 region, consistent with a heterozygous deletion.
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